Hint mode is switched on Switch off
For swift navigation between sections

LFB Biomedicaments
LEI 969500WARKTWUKB30C84

Organization name
LFB Biomedicaments
Country name
France
Country of registration
France
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

LFB Biomedicaments was incorporated in 1994. The company is a French biopharmaceutical group that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins for the treatment of serious and often rare diseases. Its therapeutic focus includes immunology, haemostasis, and intensive care. The company is a subsidiary of the LFB Group, which is owned by the French State.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    969500WARKTWUKB30C84
  • NACE
    *** ***
  • NAICS
    *** ***
  • SIREN
    491371167
Registration is required to get access.